Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairEvaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/PersistentTAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerA PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator TherapyGemcitabine Hydrochloride and Cisplatin in Treating Participants With Invasive Bladder Urothelial CancerStudy Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the PancreasNivolumab in Treating Patients With Localized Kidney Cancer Undergoing NephrectomySafety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticDocetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryConnect® MDS/AML Disease Registry
P6153
Q58845885-894EBA12-4EDA-4E52-830C-E6E13629ACBCQ61864809-DFA7C3E6-A369-4DF3-9ACB-DC95E8195E50Q61955558-62917F77-4C96-4D4F-98B3-C2D21A4CC144Q61979892-9D32584D-A0C6-447D-AC8D-7E05DF430BE8Q62812736-700D6E8D-0401-4028-820E-B0856F3F5F20Q63316114-C880D3F4-920D-4816-9FD8-D1CDF7123E6BQ63316568-4E597D51-D34C-41C0-BC7D-80E8FDFCABBBQ63339143-C8850D3C-CC48-44CA-80CF-E2FC37E58C5DQ63394116-5BEC2628-69E6-4E79-936D-49073D473011Q63397975-50C5E93B-30F6-4F35-AD9D-5AC9FB5104A9Q63570986-0C9BEAFD-3AE9-43BE-AF52-037E38D9A37DQ63574970-7876F429-2F16-4935-AC70-2973BB51B715Q64123525-33C4BC5C-E459-4A95-B956-D2BCF50ACE07Q64150411-DB0CFB00-692A-40E2-BF0B-E307B5905CB6Q64150460-CED5D3B0-A17D-4F55-A2F4-6B66F127904DQ64171079-0087347A-5D19-4464-B794-D86E99A0ADA5Q64171095-154CE27D-CA58-44B5-B7A8-42E414A87E27
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in Englewood, New Jersey
@en
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in New Jersey, Verenigde Staten van Amerika
@nl
בית חולים בארצות הברית
@he
مستشفى
@ar
name
Englewood Hospital and Medical Center
@en
type
label
Englewood Hospital and Medical Center
@en
prefLabel
Englewood Hospital and Medical Center
@en
P1566
P214
P244
P6366
P131
P1566
P213
0000 0000 9010 2182
P214
P2427
grid.414511.4
P244
P370
emergency:Yes
P571
1888-01-01T00:00:00Z
P625
Point (-73.9671 40.9049)
P6366
2800282886
P6782
P6855
P7859
lccn-n96095252